Brief: Sai Parenteral's Says Noumed Pharmaceuticals Renews OTC Supply Deal Worth $30 Million
25/08/2026 15:30
BRIEF-Sai Parenteral's Says Noumed Pharmaceuticals Renews OTC Supply Deal Worth $30 Million Aug 25 (Reuters) - Sai Parenteral's Ltd SAIP.NS:
NOUMED PHARMACEUTICALS RENEWS 3-YEAR OTC SUPPLY AGREEMENT VALUED AT A$30 MILLION
Source text: ID:nBSE8N8mmS
Further company coverage: SAIP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sai Parenteral's
See all newsIndia's Sai Parenterals rises after Australian unit renews OTC supply agreement
Brief: Sai Parenteral's Says Noumed Pharmaceuticals Renews OTC Supply Deal Worth $30 Million
India's Sai Parenterals rises after unit signs Australia supply pact
Brief: Sai Parenteral's Australian Subsidiary Renews OTC Supply Deal
Brief: Sai Parenteral's Says Unit Signs AUD 202 Million OTC Supply Agreement